Virarkar Mayur, Viswanathan Chitra, Iyer Revathy, de Castro Faria Silvana, Morani Ajaykumar, Carter Brett, Ganeshan Dhakshinamoorthy, Elsherif Sherif, Bhosale Priya R
From the Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX.
J Comput Assist Tomogr. 2019 Nov/Dec;43(6):825-834. doi: 10.1097/RCT.0000000000000918.
Accurate oncological staging for early detection is of utmost importance in patient care and increasing the overall patient survival outcome. Hybrid imaging in the form of positron emission tomography (PET)/computed tomography has been successfully implemented in oncological imaging and, where available, has been used consistently in patients with gynecologic malignancies. The implementation of PET/magnetic resonance imaging (MRI) enables high-quality assessment of gynecological malignancies by combining the diagnostic advantages of metabolic information of PET along with the high-resolution anatomical and functional information from the MRI to provide precise information about staging, recurrence, and metastases. This article will review the various applications of PET/MRI in gynecological cancer.
准确的肿瘤分期对于早期检测在患者护理以及提高患者总体生存结果方面至关重要。正电子发射断层扫描（PET）/计算机断层扫描形式的混合成像已成功应用于肿瘤成像，并且在可行的情况下，一直用于妇科恶性肿瘤患者。PET/磁共振成像（MRI）的应用通过结合PET代谢信息的诊断优势以及MRI的高分辨率解剖和功能信息，能够对妇科恶性肿瘤进行高质量评估，以提供有关分期、复发和转移的精确信息。本文将综述PET/MRI在妇科癌症中的各种应用。
